Picture of Deva Holding AS logo

DEVA.E Deva Holding AS Share Price

0.000.00%
tr flag iconLast trade - 00:00
HealthcareSpeculativeMid CapNeutral

Momentum

Relative Strength (%)
1m+2.25%
3m-16.09%
6m-27.84%
1yr+67.02%
Volume Change (%)
10d/3m-17.82%
Price vs... (%)
52w High-27.72%
50d MA-4.13%
200d MA-8.31%

Growth & Value

Shareholder Activity

TypeBuy / Hold / Sell
Institutions
Directors
Community

Guru Screens

Quality

NameIndustryMarket
Return on Capital46.09%
Return on Equity49.39%
Operating Margin39.19%

Financial Summary

Year End 31st DecUnit201820192020202120222023E2024ECAGR / Avg
Total RevenueTRYm1,040.681,373.981,863.332,330.374,477.92n/an/a41.11%
Operating Profitm
Net Profitm
EPS Reported
Diluted Normalised EPS
EPS Growth%+63.11+109.45+127.87+78.62+29.04n/an/an/a
PE Ratiox
PEG
Profitability
Operating Margin%
ROA%
ROCE%
ROE%
Cashflow
Op. Cashflow ps
Capex ps
Free Cashflow ps
Dividends
Dividend ps
Dividend Growth%
Dividend Yield%
Dividend Coverx
Balance Sheet
Cash etcm
Working Capitalm
NFAm
Net Debtm
Book Valuem
Diluted Weighted Average Sharesm
Book Value ps

Health Trend(F-Score)

12345678910

Bankruptcy Score(Z-Score)

Distress
Cautious
Safe

Earnings Manipulation Risk(M-Score)

Other Ratios

Leverage (ttm)Total- Intang+ Pension
Gross Gearing
Net Gearing
Cash / Assets

Recent History

Latest interim period vs. prior periodIndustryMarket
Sales Growth
EPS Growth
3yr Compound Annual Growth RateIndustryMarket
Sales CAGR
EPS CAGR
DPS CAGR

Graphical History

Revenue
Blurred out image of Revenue chart
Net Income
Blurred out image of Net Income chart
Normalised EPS
Blurred out image of Normalised EPS chart
PE Ratio Range
Blurred out image of PE Ratio Range chart
Dividend Yield Range
Blurred out image of Dividend Yield Range chart

Analyst Forecasts

Price target
( price)
31st Dec 202331st Dec 2024
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change

Analyst Consensus

Strong SellSellHoldBuyStrong Buy

EPS 2023 / 2024

Blurred out image of Deva Holding AS EPS forecast chart

Profile Summary

Deva Holding AS is a Turkey-based pharmaceutical company that is primarily engaged in the production and marketing of finished pharmaceutical products, pharmaceutical ingredients and veterinary products, as well as animal health products, among others. The Company has four production facilities in Turkey. Its production facilities include the Tokapi, Cerezkoy I, Cerezkoy II and Kartepe production plants. The Company’s product portfolio comprises 73 drugs, which are available on the market in 177 various forms. It offers products, such as Azitro, Alemax, Cefax, Inhibace, Imatis, Hydrea, Kardozin, Kristapen, Magcar, Magnesie Calcinee, Nostil, Oceral, Remidon, Prolixin and Quet, among others. The Company has two subsidiaries, namely Vetaa Veteriner ve Tarim Ilaclari A.S. and Deva Holding NZ Ltd.

Directors

Last Annual
December 31st, 2022
Last Interim
September 30th, 2023
Incorporated
August 22nd, 1958
Public Since
March 24th, 1986
No. of Employees
2,931
Sector
Pharmaceuticals
Industry
Healthcare
Exchange
tr flag iconIstanbul Stock Exchange
Shares in Issue
199,990,441
Blurred out image of a map
Address
Kucukcekmece, ISTANBUL, 34303
Web
https://www.deva.com.tr
Phone
+90 2126929292
Contact
Riza Yildiz
Auditors
Guney Bagimsiz denetim ve serbest muhasebeci mali musavirlik

DEVA.E Share Price Performance

Upcoming Events for DEVA.E

Q1 2024 Deva Holding AS Earnings Release

Q2 2024 Deva Holding AS Earnings Release

FAQ